← Back to searchRecruitingRecruiting
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
NCT06593327 · University of Texas Southwestern Medical Center
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Evaluation of a Pragmatic NT-ProBNP-based Heart Failure Screening Strategy Among Patients With Type 2 Diabetes: STRONG-DM Study (Screening and Treatment Using Risk-based apprOach With NT-ProBNP Guidance in Diabetes Mellitus
About this study
Primary care providers will be randomized to receive notifications via the electronic health record if any patients with diabetes have high heart failure risk based on a combination of clinical risk scores(WATCH-DM), and biomarkers (NT-proBNP). Providers will be provided recommendation to initiate evidence based therapies (SGLT2 inhibitors, GLP1 agonists, non-steroidal MRA) , obtain expert e-consultation, or refer the patient to a cardiometabolic risk management program.
Eligibility criteria
Inclusion Criteria:
* Primary Care Provider that sees diabetes patients in clinic
Exclusion Criteria:
* Provider does not see patients with Diabetes
Study design
Enrollment target: 300 participants
Allocation: randomized
Masking: none
Age groups: child, adult, older_adult
Timeline
Starts: 2025-02-10
Estimated completion: 2027-12-15
Last updated: 2026-02-27
Interventions
Behavioral: Intensive Prevention Strategy
Primary outcomes
- • Incident Heart Failure or All-cause death (2-year follow-up)
Sponsor
University of Texas Southwestern Medical Center · other
With: Roche Diagnostics GmbH
Contacts & investigators
ContactAmbarish Pandey, MD · contact · ambarish.pandey@utsouthwestern.edu · 617-869-8957
ContactVINAYAK SUBRAMANIAN, MD · contact · 2114-645-9868
All locations (1)
University of Texas Southwestern Medical CenterRecruiting
Dallas, Texas, United States